Hemoglobin (Hgb) >= g/dL (with or without transfusion support) Hemoglobin (Hgb) < g/dL without growth factor or transfusion support Hemoglobin >= g/dL (transfusion is acceptable to meet this criteria) within days of treatment initiation and must be independent of hematopoietic growth factor support Hemoglobin < . g/dL, independent of transfusion or growth factor support Hemoglobin >= g/dL (with or without transfusion support) Hemoglobin >= g/dL (with or without transfusion support) Hemoglobin >= g/dL (with or without transfusion support) within days prior to start of protocol therapy. Hemoglobin ? g/dL, with or without transfusion support STRATUM A: Hemoglobin >= . g/dL without support of a blood transfusion within days of the test STRATUM B: Hemoglobin >= . g/dL without support of a blood transfusion within days of the test STRATUM C: Hemoglobin >= . g/dL without support of a blood transfusion within days of the test Hemoglobin ? . g/dL without transfusion support within days prior to study treatment (erythropoietin or darbepoetin permitted) Hemoglobin (HGB) >= g/dl without transfusion or growth factor support for at least week Hemoglobin >= g/dL, with or without transfusion support; NOTE: If the patients bone marrow biopsy shows greater than or equal to % plasma cells, hemoglobin > g/dL (transfusion support or growth factor support is acceptable) Bone marrow reserve consistent with: hemoglobin >= g/dL values must be obtained without the need for myeloid growth factor support, platelet or PRBC transfusion support within days Requiring blood product support Hemoglobin concentration > g/dL (with or without support) Hemoglobin >= . g/dL without transfusion support within the past days (erythropoietin or darbepoetin permitted) Hemoglobin >= g/dL (with or without support) Requiring blood product support Hemoglobin ? g/dL, without transfusion support within days preceding the lab assessment. Hemoglobin ?. g/dL with or without transfusion support Hemoglobin >= g/dL (Note: no transfusion within days. Ongoing growth factor support is acceptable if on a stable dose for the past days), within days of day . Requiring blood product support Requiring blood product support Hemoglobin > g/dL (without transfusion support within days from start of leukapheresis) Screening hematology values of the following: absolute neutrophil count ? /?L, platelets ? ,/?L, hemoglobin ? g/dL (without transfusion support); Hemoglobin > . without transfusion support in the past days Hemoglobin ? . g/dL with or without transfusion support Hemoglobin >= g/dL. No transfusion or growth factor support for one week prior to labs. Hemoglobin >= g/dl (transfusion support allowed) Hemoglobin >= g/dL without need for hematopoietic growth factor or transfusion support within days prior to treatment initiation Hemoglobin >= . g/dl with transfusion support Hemoglobin >= . g/dL (without transfusion or growth factor support) Hemoglobin concentration > g/dL (with or without support) Hemoglobin >= g/dL (transfusion support allowed) Hemoglobin >= g/dL (without platelet transfusion or myeloid growth factor support within two weeks of screening) Hemoglobin >= . g/dl (transfusion and/or growth factor support allowed) Hemoglobin >= .g/dL (without need for transfusion support within days; growth factor allowed) Hemoglobin >/= . g/dL without transfusion support Hemoglobin ? g/dL, independent of transfusion or growth factor support Hemoglobin > mg/dL without need for hematopoetic growth factor or transfusion support Screening blood counts of the following: Absolute neutrophil count ? /?L, Platelets ? ,/?L, Hemoglobin ? g/dL (with transfusion support); Hemoglobin ? g/dL without need for hematopoietic growth factor or transfusion support Anemia, defined as hemoglobin < gram per deciliter (g/dL) or > g/dL below lower limit of normal or both; transfusion support or concurrent treatment with erythropoietin stimulating agents is not permitted Hemoglobin >= . g/dL without transfusion support > days prior to registration Hemoglobin ? g/dL(without transfusion support)